Skip to main content
. 2022 Feb 22;90(5):515–522. doi: 10.1227/neu.0000000000001875

FIGURE 1.

FIGURE 1.

Oncoplot of oligodendroglioma, IDH-mutant, and 1p/19q-codeleted patients. IDH, isocitrate dehydrogenase; OS, overall survival; PFS, progression-free survival; PCV, procarbazine, lomustine, and vincristine; RT, radiotherapy; TMZ, temozolomide.